PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30108868-5	2017	In this paper, we report the development of two series of quinazolinone derivatives incorporating hydrazinecarbothioamide (compounds 3a-g) and the hydrazino group (compounds 4a-e) as linkers for developing CCK-BR antagonists.	Quinazolinones	58-71	cholecystokinin B receptor	Mus musculus	206-212	
15607491-1	2004	A quinazolinone derivative as a novel non-peptidic CCK-B receptor antagonist designated as Qn-In, was synthesized, characterized by spectroscopic techniques and evaluated for radiopharmaceutical potential.	Quinazolinones	2-15	cholecystokinin B receptor	Mus musculus	51-65